The cluster shows no active-manager buying conviction; passive rebalancing dominates the buy side while a quant and a passive manager both sold heavily. Monitor for further insider selling (7 sells in 30d) and any catalyst-driven reversal. The net negative institutional flow suggests caution.
REPL drugs
REPL drug pipeline →How the stock moved after the report
BEARISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 11 $8.62entry
- T+1 · 5mo ago +3.02%α +2.48% · $8.88
- T+5 · 5mo ago +16.01%α +15.58% · $10.00
- T+20 · 4mo ago +28.89%α +27.00% · $11.11
- T+60 · 2mo ago +74.48%α +70.08% · $15.04
How similar events traded
Executive Summary
In Q3 2025, four mega-passive institutions (Fidelity, Morgan Stanley, Invesco, UBS) increased their REPL holdings by a net $320K, while two sellers (Citadel and BofA) reduced by $6.3M. The cluster is dominated by passive rebalancing, not active conviction, and the net selling pressure outweighs buying, suggesting no strong shared bullish thesis.
Key Financial Metrics
Institutional Positions
Net institutional flow: -$6.0M
▲ Buyers (4)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Fidelity | DOUBLED | +247.5% | $5.7M | $2.1M |
| Morgan Stanley | ADD | +49.2% | $5.8M | -$2.8M |
| Invesco | ADD | +29.3% | $647.0K | -$462.0K |
| UBS | DOUBLED | +270.4% | $3.8M | $1.5M |
▼ Sellers (2)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Citadel | TRIM | -56.7% | $2.6M | -$2.1M |
| BofA | NEAR_EXIT | -78.4% | $4.7M | -$4.2M |
Key Facts
- 4 buyers added $15.9M in current holdings, net change +$320K
- 2 sellers reduced by $6.3M, led by BofA near-exit (-$4.2M) and Citadel trim (-$2.1M)
- All buyers are mega-passive/index funds (Fidelity, Morgan Stanley, Invesco, UBS), low signal conviction
- Sellers include a quant fund (Citadel) and a passive manager (BofA), both reducing significantly
- Net institutional flow is negative: sellers removed $6.3M vs buyers added only $320K
Financial Impact
Net institutional selling of approximately $6.0M (sellers $6.3M minus buyers $0.32M)
Risk Factors
- Passive buying may reverse if index rebalancing ends
- Insider selling pattern (7 sells in 30d) aligns with institutional distribution
- Low analyst bullishness (8% buy rating) and small market cap ($699M) increase volatility
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-REPL-2025-Q3 |
Track record
32 reports on REPL
9 of 12 bullish or bearish reports moved the stock their way by T+60. Best: +188.35% at T+20 after the Jul 30, 2026 report. 13 of 13 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $21.90 settles Feb 12
- Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $21.78 settles Feb 9
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $23.28 settles Feb 8
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $23.28 settles Feb 8
- Nov 9, 20267d ago SC 13G/A Neutral 2/10 Entry $22.26 settles Feb 5
- Nov 6, 202610d ago 10-Q/A Neutral 3/10 Entry $22.26 settles Feb 5
- Nov 4, 202612d ago Institutional Cluster Bearish 4/10 Entry $20.69 settles Feb 2
- Nov 3, 202613d ago 144 Neutral 2/10 Entry $20.69 settles Feb 2
- Nov 2, 202614d ago 144 Neutral 2/10 Entry $20.65 settles Feb 1
- Oct 30, 202617d ago 144 Neutral 2/10 Entry $19.49 settles Jan 29
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers